Boston Therapeutics Inc Stock Price - BTHE

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Boston Therapeutics (QB) BTHE OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00085 8.5% 0.01085 0.0117 0.01085 0.0117 0.01 16:59:49
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 38,700 $ 0.0117 $ 453 57,562 0.0091 - 0.05
Last Trade Time Type Quantity Stock Price Currency
12:42:42 20,000 $ 0.01085 USD

Boston Therapeutics Inc Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.21M 111.13M $ -4.60M - - 43.38M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Boston Therapeutics Inc News

Date Time Source News Article
9/25/201908:31Edgar (US Regulatory)Current Report Filing (8-k)
8/19/201909:48Edgar (US Regulatory)Quarterly Report (10-q)
8/14/201909:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late..
5/20/201914:54Edgar (US Regulatory)Quarterly Report (10-q)
5/15/201913:49Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late..
4/16/201915:41Edgar (US Regulatory)Annual Report (10-k)
4/01/201917:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt..

Latest BTHE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTHE Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.00920.01170.00920.009320k0.0016517.93%
1 Month0.0120.01290.00920.011121k-0.00115-9.58%
3 Months0.01880.03320.00910.016283k-0.00795-42.29%
6 Months0.0210.0350.00910.019270k-0.01015-48.33%
1 Year0.03390.050.00910.026872k-0.02305-67.99%
3 Years0.13240.150.00910.044447k-0.12155-91.81%
5 Years0.2960.80.00910.077545k-0.28515-96.33%

Boston Therapeutics Inc Description

Boston Therapeutics, Inc. (OTCQB: BTHE), headquartered in Lawrence, MA, is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: BTI-320, a non-systemic chewable compound designed to reduce post-meal glucose elevation; IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia; and SUGARDOWN(R), an OTC dietary supplement designed to lower post-meal sugar spike. More information on BTHE is available at
Your Recent History
Boston The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191020 18:46:00